Postoperative suppressive therapy for thyroid adenomas

Robert S Krouse, T. McCarty, L. M. Weiss, L. D. Wagman

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Thyroid adenoma is a common disease. If partial thyroidectomy is performed, postoperative suppression therapy is often given to avoid nodule development in the remaining thyroid. It is unclear whether this treatment is warranted. Patients who underwent a partial thyroidectomy with a histologic diagnosis of follicular thyroid adenoma from January 1985 until February 1998 were studied retrospectively. Patients were analyzed on the basis of postoperative therapy, new thyroid nodule growth, and costs. Seventy-six patients were identified with a recurrence rate of 4 per cent (3/76). Sixty-one per cent (46/76) were treated with postoperative thyroid suppression therapy, and no difference in new nodule development was noted with at least 6 months of follow-up (P = 0.274). No patients required reoperation. A large cost saving was shown for patients who were not treated with levothyroxine. We conclude that postoperative thyroid suppression may not be routinely indicated. A prospective, randomized study would be necessary to answer this question conclusively.

Original languageEnglish (US)
Pages (from-to)751-755
Number of pages5
JournalAmerican Surgeon
Volume66
Issue number8
StatePublished - 2000
Externally publishedYes

Fingerprint

Thyroid Neoplasms
Thyroid Gland
Thyroidectomy
Therapeutics
Costs and Cost Analysis
Thyroid Nodule
Thyroxine
Reoperation
Adenoma
Prospective Studies
Recurrence
Growth

ASJC Scopus subject areas

  • Surgery

Cite this

Krouse, R. S., McCarty, T., Weiss, L. M., & Wagman, L. D. (2000). Postoperative suppressive therapy for thyroid adenomas. American Surgeon, 66(8), 751-755.

Postoperative suppressive therapy for thyroid adenomas. / Krouse, Robert S; McCarty, T.; Weiss, L. M.; Wagman, L. D.

In: American Surgeon, Vol. 66, No. 8, 2000, p. 751-755.

Research output: Contribution to journalArticle

Krouse, RS, McCarty, T, Weiss, LM & Wagman, LD 2000, 'Postoperative suppressive therapy for thyroid adenomas', American Surgeon, vol. 66, no. 8, pp. 751-755.
Krouse RS, McCarty T, Weiss LM, Wagman LD. Postoperative suppressive therapy for thyroid adenomas. American Surgeon. 2000;66(8):751-755.
Krouse, Robert S ; McCarty, T. ; Weiss, L. M. ; Wagman, L. D. / Postoperative suppressive therapy for thyroid adenomas. In: American Surgeon. 2000 ; Vol. 66, No. 8. pp. 751-755.
@article{2e6d74be51af4193b1859fa8c47c7c8c,
title = "Postoperative suppressive therapy for thyroid adenomas",
abstract = "Thyroid adenoma is a common disease. If partial thyroidectomy is performed, postoperative suppression therapy is often given to avoid nodule development in the remaining thyroid. It is unclear whether this treatment is warranted. Patients who underwent a partial thyroidectomy with a histologic diagnosis of follicular thyroid adenoma from January 1985 until February 1998 were studied retrospectively. Patients were analyzed on the basis of postoperative therapy, new thyroid nodule growth, and costs. Seventy-six patients were identified with a recurrence rate of 4 per cent (3/76). Sixty-one per cent (46/76) were treated with postoperative thyroid suppression therapy, and no difference in new nodule development was noted with at least 6 months of follow-up (P = 0.274). No patients required reoperation. A large cost saving was shown for patients who were not treated with levothyroxine. We conclude that postoperative thyroid suppression may not be routinely indicated. A prospective, randomized study would be necessary to answer this question conclusively.",
author = "Krouse, {Robert S} and T. McCarty and Weiss, {L. M.} and Wagman, {L. D.}",
year = "2000",
language = "English (US)",
volume = "66",
pages = "751--755",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "8",

}

TY - JOUR

T1 - Postoperative suppressive therapy for thyroid adenomas

AU - Krouse, Robert S

AU - McCarty, T.

AU - Weiss, L. M.

AU - Wagman, L. D.

PY - 2000

Y1 - 2000

N2 - Thyroid adenoma is a common disease. If partial thyroidectomy is performed, postoperative suppression therapy is often given to avoid nodule development in the remaining thyroid. It is unclear whether this treatment is warranted. Patients who underwent a partial thyroidectomy with a histologic diagnosis of follicular thyroid adenoma from January 1985 until February 1998 were studied retrospectively. Patients were analyzed on the basis of postoperative therapy, new thyroid nodule growth, and costs. Seventy-six patients were identified with a recurrence rate of 4 per cent (3/76). Sixty-one per cent (46/76) were treated with postoperative thyroid suppression therapy, and no difference in new nodule development was noted with at least 6 months of follow-up (P = 0.274). No patients required reoperation. A large cost saving was shown for patients who were not treated with levothyroxine. We conclude that postoperative thyroid suppression may not be routinely indicated. A prospective, randomized study would be necessary to answer this question conclusively.

AB - Thyroid adenoma is a common disease. If partial thyroidectomy is performed, postoperative suppression therapy is often given to avoid nodule development in the remaining thyroid. It is unclear whether this treatment is warranted. Patients who underwent a partial thyroidectomy with a histologic diagnosis of follicular thyroid adenoma from January 1985 until February 1998 were studied retrospectively. Patients were analyzed on the basis of postoperative therapy, new thyroid nodule growth, and costs. Seventy-six patients were identified with a recurrence rate of 4 per cent (3/76). Sixty-one per cent (46/76) were treated with postoperative thyroid suppression therapy, and no difference in new nodule development was noted with at least 6 months of follow-up (P = 0.274). No patients required reoperation. A large cost saving was shown for patients who were not treated with levothyroxine. We conclude that postoperative thyroid suppression may not be routinely indicated. A prospective, randomized study would be necessary to answer this question conclusively.

UR - http://www.scopus.com/inward/record.url?scp=0033886091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033886091&partnerID=8YFLogxK

M3 - Article

C2 - 10966034

AN - SCOPUS:0033886091

VL - 66

SP - 751

EP - 755

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 8

ER -